Print Issue: January 01, 2007

Full Correction of Anemia May Be Bad

Achieving high hemoglobin levels in patients with CKD anemia may confer no cardiovascular benefit and could even increase the risk of death and cardiac problems, according to two studies published in the New England Journal of Medicine (2006;355:2071-2084;2085-2098).

Anemia Studies Not the Final Word

The recent publication of the CHOIR and CREATE studies in the New England Journal of Medicine questioning hemoglobin targets in dialysis patients have resulted in intense scrutiny of the relationship between Amgen, dialysis organizations, and physicians in the management of anemia.

Duloxetine May Relieve OAB Symptoms

Duloxetine, a serotonin-noradrenalin reuptake inhibitor, may be an effective treatment for women with symptoms of overactive bladder (OAB). Duloxetine is marketed as Cymbalta for treating depression and diabetic peripheral neuropathy.

Dialysis Centers Go Patient Friendly

A mural featuring a sun-dappled lake, crimson and azure birds, lush flowers, and palm trees adorns one waiting room wall. In another, a comfy couch beckons; a cheery blaze crackles in the fireplace, and the aroma of hot coffee wafts from an adjacent kitchenette.

Cuffed Catheters Are Riskier

Cuffed Catheters Are Riskier

SAN DIEGO—Cuffed catheters for hemodialysis patients are associated with a 46% higher risk of septicemia or endocarditis compared with temporary catheters, according to a study of nearly 30,000 patients.

CRP Predicts Worse RCC Survival

High preoperative C-reactive protein (CRP) levels are associated with worse survival in patients who undergo radical nephrectomy for localized renal cell carcinoma (RCC), according to investigators.

Next post in News